ARTICLE | Product Development
Cell therapy momentum at ASH
A survey of clinical abstracts at ASH 2018 highlights momentum in CAR Ts
December 1, 2018 3:50 AM UTC
This year’s American Society of Hematology (ASH) meeting will showcase a surge in clinical CAR T cell presentations. But gene therapies are not following the same trajectory, despite both modalities being fresh off their first approvals.
In advance of the meeting, which will be held Dec. 1-4 in San Diego, BioCentury applied a series of manual and algorithm-guided analyses of the abstracts, and identified 2,209 that involve clinical studies of therapeutics, diagnostics or prognostic biomarkers. ...
BCIQ Company Profiles